LD-2 disclosure · Registration
AURAVAX THERAPEUTICS
Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.
Client
- Description
- Biopharmaceutical company
- Location
- Texas · United States of America
Registrant
- Description
- ​Federal and Foundation Grants and Government Relations consulting firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.
LobbyistsANDREW QUINN · ELIZABETH FOLEY · JASON HOIS
Covered position (ANDREW QUINN): SA, LA - Rep. Hoyer
Covered position (ELIZABETH FOLEY): LA - Rep. McCollum
Health Issues
Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.
LobbyistsANDREW QUINN · ELIZABETH FOLEY · JASON HOIS
Covered position (ANDREW QUINN): SA, LA - Rep. Hoyer
Covered position (ELIZABETH FOLEY): LA - Rep. McCollum
Defense
Department of Defense Appropriations No bill number - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.
LobbyistsANDREW QUINN · ELIZABETH FOLEY · JASON HOIS
Covered position (ANDREW QUINN): SA, LA - Rep. Hoyer